NutriBand (NTRB) EBIT Margin (2018 - 2026)

NutriBand's (NTRB) quarterly EBIT Margin came in at 254.78% in Q1 2026, up 61057.0% year-on-year from N/an in Q1 2025, and up 77.28% quarter-over-quarter from 1121.3% in Q4 2025.

NutriBand (NTRB) EBIT Margin (2018 - 2026) Analysis & Trends

NutriBand has disclosed EBIT Margin across 9 years of filings, most recently posting 254.78% for Q1 2026.

  • EBIT Margin for Q1 2026 came in at 254.78%, up 61057.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 408.41% (up 7229.0% YoY), and the FY2026 annual result was 408.41%, up 7229.0% from the prior year.
  • EBIT Margin came in at 254.78% for Q1 2026 at NutriBand, up from 1121.3% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 125.65% in Q3 2023 to a low of 1121.3% in Q4 2025.
  • The 5-year median for EBIT Margin is 254.78% (2026), against an average of 376.35%.
  • Across the five-year window, EBIT Margin slumped 90035 bps in 2025 and surged 61057 bps in 2026, its largest moves.
  • NutriBand's EBIT Margin stood at 173.38% in 2022, then plunged by 132 bps to 402.84% in 2023, then soared by 45 bps to 220.94% in 2024, then plunged by 408 bps to 1121.3% in 2025, then soared by 77 bps to 254.78% in 2026.
  • The last three EBIT Margin figures came in at 254.78% (Q1 2026), 1121.3% (Q4 2025), and 321.83% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 38.10%
9 Abivax 94.37 Bn 94.37 Bn - -
10 NutriBand 41.91 Mn 37.33 Mn 88,941.00 -254.78%

Historic Data

Download Data
DateValue
Jan 31, 2026 -254.78%
Oct 31, 2025 -1,121.30%
Jul 31, 2025 -321.83%
Apr 30, 2025 -211.78%
Jan 31, 2025 -865.34%
Oct 31, 2024 -220.94%
Jul 31, 2024 -318.35%
Apr 30, 2024 -462.50%
Jan 31, 2024 -249.01%
Oct 31, 2023 -402.84%
Jul 31, 2023 -125.65%
Apr 30, 2023 -213.42%
Jan 31, 2023 -319.13%
Oct 31, 2022 -173.38%
Jul 31, 2022 -226.73%
Apr 30, 2022 -143.51%
Jan 31, 2022 -767.47%
Oct 31, 2021 -543.55%
Jul 31, 2021 -225.62%
Apr 30, 2021 -72.45%